50 likes | 69 Views
Global Psoriasis Drugs Market Size, Competitive Analysis, Share, Forecast- 2019-2025
E N D
Global Psoriasis Drugs Market Size, Competitive Analysis, Share, Forecast- 2019-2025 Request a Free Sample @ https://www.omrglobal.com/request-sample/psoriasis-drugs- market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404 The global psoriasis market is estimated to grow significantly during the forecast period. Psoriasis is a genetic condition in which skin cells build up and form scales and itchy, dry patches. It is also considered an immune system problem, that causes rashes on the skin. The primary treatment for psoriasis is medications, that aim to eliminate scales and prevent skin cells from growing rapidly. Topical ointments, light therapy, and medication can also offer relief in psoriasis itchiness. Get Free Sample Copy @https://www.omrglobal.com/request-sample/psoriasis-drugs- market The primary factors that drive the growth of the market include the increased incidences of psoriasis cases across the globe. As per the National Psoriasis Foundation in 2020, more than 8 million Americans suffer from psoriasis. According to the World Psoriasis Day consortium, globally 125 million people that is more than 3% of the total population suffers from psoriasis. Further, the increasing disease burden and demand for psoriasis medicines along with the rapid R&D activities in psoriasis research and pipeline drugs are some of the factors supporting the growth of the market.
Moreover, the crucial factor includes the availability of advanced treatment methods. For instance, the integration of biologics with the drugs for the treatment of psoriasis is also gaining traction. Biologics are those drugs that target only specific parts of the immune system and provides better management and control on the symptoms of psoriasis. Being effective in the treatment of moderate to severe cases of psoriasis, biologics is projected to gain traction during the forecast period and hence will enhance the growth of the market globally. Browse for Full Report Description@ https://www.omrglobal.com/industry- reports/psoriasis-drugs-market Market Segmentation 5.1. Global Psoriasis Drugs Market by Drug Class Tumor Necrosis Factor (TNF) Inhibitors Interleukin Inhibitors Vitamin D Analogs Others Global Psoriasis Drugs Market by Route of Administration Oral Parenteral Topical Regional Analysis North America United States Canada Europe
UK Germany Italy Spain France Rest of Europe Asia-Pacific China India Japan Rest of Asia-Pacific Rest of the World Company Profiles AbbVie, Inc. Amgen Inc. AstraZeneca Plc Bausch Health Companies Inc. Biogen, Inc. Boehringer Ingelheim International GmbH Celltrion Healthcare Co. Ltd. Dr. Reddy's Laboratories Ltd. Eli Lilly and Co. Johnson & Johnson Services Inc. LEO Pharma A/S Merck & Co. Inc. Novartis International AG Pfizer, Inc. Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd. UCB SA For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/psoriasis-drugs-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404